Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Neubase Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
NBSE
Nasdaq
8731
https://www.neubasetherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Neubase Therapeutics Inc
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
- Apr 5th, 2024 8:05 pm
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
- Nov 27th, 2023 2:00 pm
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder
- Sep 8th, 2023 11:00 am
SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
- Sep 6th, 2023 2:00 pm
NeuBase Therapeutics to Explore Strategic Alternatives
- Aug 3rd, 2023 11:00 am
NeuBase Announces Closing of $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
- Jun 30th, 2023 8:05 pm
NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to Redosing
- Jun 29th, 2023 12:30 pm
NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
- Jun 28th, 2023 6:17 pm
NeuBase Announces 1-for-20 Reverse Stock Split
- Jun 14th, 2023 12:30 pm
NeuBase to Participate in Jefferies Healthcare Conference
- May 24th, 2023 12:00 pm
NeuBase Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors™
- May 22nd, 2023 11:00 am
NeuBase Announces Formation of Gene Editing Advisory Board
- May 16th, 2023 8:01 pm
NeuBase Reports Business Update and Financial Results for the First Quarter of 2023
- May 11th, 2023 8:15 pm
NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting
- May 2nd, 2023 9:00 pm
Scroll